文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > Diagnosis and management of non-alcoholic fatty liver
侵权投诉

Diagnosis and management of non-alcoholic fatty liver

bs_bs_banner

Journal of Diabetes (2013) –

R E V I E W A RT I C L E

Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology Xin GAO,1 and Jian-Gao FAN2 for the Study Group of Liver and Metabolism, Chinese Society of Endocrinology 1 Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University and 2Department of Gastroenterology, Xinhua Hospital, Shanghai, China

Correspondence Xin Gao, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. Tel:+86 21 6404 1990 8021 Fax:+86 21 6403 7269 Email: gao.xin@zs-hospital.sh.cn Received 25 July 2012; revised 17 March 2013; accepted 3 April 2013. doi: 10.1111/1753-0407.12056

Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries, affecting 20%–33% of the general population. Large population-based surveys in China indicate a prevalence of approximately 15%–30%. Worldwide, including in China, the prevalence of NAFLD has increased rapidly in parallel with regional trends of obesity, type2 diabetes and metabolic syndrome. In addition, NAFLD has contributed signi cantly to increased overall, as well as cardiovascular and liver-related, mortality in the general population. In view of rapid advances in research into NAFLD in recent years, this consensus statement provides a brief update on the progress in the eld and suggests preferred approaches for the comprehensive management of NAFLD and its related metabolic diseases. Keywords: NAFLD, metabolic disorders, diagnosis, management.

Introduction Non-alcoholic fatty liver disease (NAFLD) is de ned as liver fat accumulation exceeding 5% by weight that is not the result of excessive alcohol consumption, drugs, toxins, infectious diseases or any other identi able causes. It is a spectrum of disorders ranging from simple fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) with or without brosis/cirrhosis.1 Even a small proportion of NAFLD patients can advance to hepatocellular carcinoma (HCC). Histologically, NAFL is de ned as the presence of hepatic steatosis with no evidence of hepatocellular injury (e.g. the form of ballooning hepatocytes), whereas NASH is de ned as the presence of hepatic steatosis and in ammation with hepatocyte injury, with or without brosis. In Western countries, NAFLD is the most common liver disorder, affecting 20%–33% of the general population.2,3 In patients with obesity and diabetes, the prevalence of NAFLD is 57.5%–74.0% and 21–78%,

respectively.4 There is strong evidence that the prevalence of NAFLD has been increasing rapidly in the Asia Paci c region in recent years, approaching levels seen in Western countries.5 In China, the prevalence of NAFLD is also of concern. The prevalence of NAFLD has b

een found to be approximately 15% in Shanghai6 and nearly 30% in Hong Kong, as determined by accurate proton magnetic resonance spectroscopy.7 The risk factors for NAFLD include changes in lifestyle, notably the adoption of a high-fat diet and physical inactivity, and the presence of metabolic syndrome or its components, including central abdominal obesity, hypertension, dyslipidemia and type 2 diabetes (T2D).8 It is likely that NAFLD is the hepatic manifestation of metabolic syndrome where insulin resistance is the main risk factor.2 Many recent studies have reported that the increase in the prevalence of NAFLD is associated with increases in the prevalence of prediabetes, diabetes, and cardiovascular disease.9,10 There is also evidence that the prevalence of NAFLD prevalence is affected by age,

© 2013 The Authors. Journal of Diabetes published by Wiley Publishing Asia Pty Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine. 1 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Diagnosis and management of non-alcoholic fatty liver

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email